CPG for the incorporation of unmodified ribo-A at the 3' end of an oligonucleotide, with 2'-OAc protection
CPG for incorporation of unmodified ribo-G at 3' end of an oligonucleotide.
CPG for incorporation of a 2'-fluoro modified ribo-G nucleobase at the 3' end of an oligonucleotide
CPG for incorporation of a 2'-fluoro modified ribo-C nucleobase at the 3' end of an oligonucleotide
CPG for the incorporation of a 2'-fluoro modified ribo-A nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of a 2'-O-methyl modified ribo-C nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of a 2'-fluoro modified U nucleobase at the 3' end of an oligonucleotide
CPG for the incorporation of amino-C7 at the 3' end of an oligonucleotide, with Fmoc protection.
CPG for the incorporation of cholesterol at the 3' end of an oligonucleotide, with a triethylene glycol spacer.
Long-chain alkyl-amino CPG for base or modifier functionalisation.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 5304 2200 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 5304 2200 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |
